The weight loss achieved with the high dose of the drug was much higher than the 1.7 per cent reduction with a placebo in one part of the trial that involved 48 participants. Another part of the early-stage study was testing the drug in 20 people with lower doses.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/IUbBy27
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment